Travere Therapeutics (TVTX) Earnings
|
Expand Research on TVTX
| Next EPS Date | 7/30/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +327.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +4.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/30/26  |
Q226 | N/A | -$0.05 | N/A | N/A | $162.69M | N/A | N/A | N/A | ||
| 5/4/26 | Q126 | -$0.40 | -$0.23 | -$0.17 | $127.2M | $137.34M | N/A |  | | Details | |
| 2/19/26 | Q425 | $0.37 | -$0.04 | +$0.41 | $129.69M | $145.23M | N/A | | | Details | |
| 10/30/25 | Q325 | $0.59 | -$0.29 | +$0.88 | $164.9M | $105.57M | N/A | | | Details | |
| 8/6/25 | Q225 | -$0.14 | -$0.30 | +$0.16 | $114.4M | $99.25M | N/A | | | Details | |
| 7/31/25 |
Q225 | N/A | -$0.30 | N/A | N/A | $99.25M | N/A | N/A | N/A | ||
| 5/1/25 | Q125 | -$0.19 | -$0.55 | +$0.36 | $81.73M | $78.05M | N/A | | | Details | |
| 2/20/25 | Q424 | -$0.47 | -$0.64 | +$0.17 | $74.79M | $71.08M | N/A | | | Details |
